Allarity Therapeutics ALLR
NASDAQ ALLR
$1.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Selling, General & Administrative (2020 - 2026)

Updated

Allarity Therapeutics' Selling, General & Administrative came in at $1.33 million for Q2 2026, down 26.8% from $1.81 million a year earlier and down 6.4% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Allarity Therapeutics reported Selling, General & Administrative of $5.62 million, down 46.5% year-over-year; for FY2025, it came in at $6.32 million, down 44.7% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $11.44 million in FY2024 (+14.1%), $10.03 million in FY2023 (+0.6%), $9.96 million in FY2022 (-19.4%) and $12.36 million in FY2021 (+201.4%).
  • The five-year range for quarterly Selling, General & Administrative is $1.32 million (Q3 2025) to $6.22 million (Q4 2021).
  • Year-over-year, Selling, General & Administrative has declined for six consecutive quarters, with an average decline of 8.1% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2021 (growth of 626.6%), and the weakest in Q4 2025 (a decline of 71.4%).
  • Business Quant data shows ALLR's Selling, General & Administrative at $1.42 million (Q1 2026), $1.56 million (Q4 2025) and $1.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Allarity Therapeutics 1.67 Mn 1.67 Mn - 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 1.42 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 5.47 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 2.07 Mn
Dec 31, 2023 2.26 Mn
Sep 30, 2023 2.48 Mn
Jun 30, 2023 3.05 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 2.25 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 3.15 Mn
Mar 31, 2022 3.01 Mn
Dec 31, 2021 6.22 Mn
Sep 30, 2021 2.62 Mn
API Access

Allarity Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALLR&period=max&api_key=YOUR_API_KEY